Clinical Trial

Virtual Reality Cognitive Stimulation for Alzheimer's

Study acronym: CODDI
Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate whether immersive virtual reality (VR) can improve cognitive function and memory in patients with Alzheimer's disease. Twenty participants in Burgos, Spain, will engage in VR sessions that recreate scenes from 1960s Burgos, representing environments familiar from the participants' youth. The effects of these VR-based cognitive stimulation sessions will be assessed through pre- and post-intervention evaluations, including behavioral observations, EEG monitoring of brain activity, and standardized neurocognitive tests (Montreal Cognitive Assessment, Clock-Drawing Test, and Verbal Fluency Test).
Trial Details
NCT Number NCT07645638
Lead Sponsor Universidad de Burgos
Conditions Alzheimer Disease, Memory Disorders
Enrollment 33 participants
Start Date 2025-01-08
Primary Completion 2025-03-20 (estimated)
Study Completion 2025-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-12